Back
OptiNose 10K Form
Buy
51
OPTN
OptiNose
Last Price:
$9.42
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OPTN News And Ratings
See the #1 stock for the next 7 days that we like better than OPTN
OPTN Financial Statistics
Sales & Book Value
| Annual Sales: | $78.2M |
|---|---|
| Cash Flow: | $1.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-4.01 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.84620 |
|---|---|
| Net Income (TTM): | $-21.5M |
| Gross Margin: | $71M |
| Return on Equity: | 0% |
| Return on Assets: | -18.47% |
OptiNose Earnings Forecast
Key OptiNose Financial Ratios
-
The Gross Profit Margin over the past 8 years for OPTN is 90.76%.
-
The Selling, General & Administrative Expenses for OPTN have been equal to 106.69% of Gross Profit Margin.
-
The Research & Development expenses have been 4.93% of Revenue.
-
The Net Earning history of OPTN is -27.54% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 8 years.
OptiNose Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OPTN |
| CUSIP: | 68404V |
| Website: | optinose.com |
Debt
| Debt-to-Equity Ratio: | -3.13 |
|---|---|
| Current Ratio: | 0.77 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 44.53 |